High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic EventsEvangelos Terpos, Meletios Α. Dimopoulos, Efrosyni Merkouri et al.|Vaccines|2021Cited by 30